Departed
Martin Beck
Chief Financial Officer
UpHealth, Inc.
the Board determined that Mr. Beck would no longer serve as the Company’s Chief Financial Officer
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8201–8250 of 18654
Departed
Samuel J. Meckey
Chief Executive Officer
UpHealth, Inc.
On October 6, 2023, UpHealth, Inc. (the “Company”) notified Samuel J. Meckey that pursuant to a decision made by t he Board of Directors (the “Board”) on October 5, 2023, his service as the Chief Executive Officer of the Company was terminated, effective immediately
Departed
Derrek Gafford
Executive Vice President and Chief Financial Officer
TBI ·
TrueBlue, Inc.
Mr. Gafford will continue to serve as the Company’s Executive Vice President and Chief Financial Officer until October 30, 2023.
Appointed
Carl Schweihs
Executive Vice President and Chief Financial Officer
TBI ·
TrueBlue, Inc.
Carl Schweihs, currently Executive Vice President and President of the Company’s PeopleManagement Division, will become Executive Vice President and Chief Financial Officer of the Company, succeeding Derrek Gafford, effective October 30, 2023.
Departed
Michael A. Farlekas
Chief Executive Officer
E2open Parent Holdings, Inc.
Mr. Michael A. Farlekas agreed that Mr. Farlekas would depart the Company as an employee and cease serving as its Chief Executive Officer (“CEO”) and on its board of directors (the “Board”).
Appointed
(interim)
Andrew Appel
Interim CEO
E2open Parent Holdings, Inc.
The Board has appointed Mr. Andrew Appel as interim CEO (“Interim CEO”) and a director of the Company.
Role change
Diron Smith
Chief Financial Officer
ITGR ·
Integer Holdings Corp
The Board of Directors of Integer Holdings Corporation (the “Company”) has appointed Diron Smith, who currently serves as the Company’s Vice President and Interim Chief Financial Officer, as the Executive Vice President and Chief Financial Officer (“CFO”) of the Company, effective October 9, 2023.
Appointed
Brenda Lovcik
Senior Vice President and Chief Financial Officer
TREX ·
TREX CO INC
On October 5, 2023 the Board of Directors and the Compensation Committee of Trex Company, Inc. (Company) appointed Brenda Lovcik to serve as the Company’s Senior Vice President and Chief Financial Officer effective October 23, 2023.
Appointed
Cameron Turtle
principal executive officer
SYRE ·
Spyre Therapeutics, Inc.
On October 6, 2023, the Board of Directors (the “Board”) of Aeglea BioTherapeutics, Inc. (the “Company”) appointed Dr. Cameron Turtle, the Company’s Chief Operating Officer, as the principal executive officer of the Company, effective as of the same day.
Role change
Kristin Yarema
President and Chief Executive Officer
Poseida Therapeutics, Inc.
approved a leadership transition appointing Kristin Yarema, Ph.D., as President and Chief Executive Officer of the Company.
Departed
John Riccitiello
President and Chief Executive Officer
U ·
Unity Software Inc.
On October 9, 2023, the Company announced that John Riccitiello will retire as the Company’s President and Chief Executive Officer and as a member of the Company’s Board of Directors (the “Board”), effective immediately.
Appointed
(interim)
James Whitehurst
Interim Chief Executive Officer and President
U ·
Unity Software Inc.
On October 9, 2023, the Company announced the appointment of James Whitehurst, age 55, to serve as the Company’s Interim Chief Executive Officer and President and as a member of the Board, effective immediately.
Departed
Derrick Sung
Chief Financial Officer
LUNG ·
Pulmonx Corp
On October 6, 2023, Derrick Sung, Ph.D., Chief Financial Officer of the Company, stepped down from his position, effective October 10, 2023 (the “ Effective Date ”), to pursue a new business opportunity.
Appointed
(interim)
John McKune
Interim Chief Financial Officer
LUNG ·
Pulmonx Corp
John McKune, Vice President, Corporate Controller of the Company, was appointed by the Board of Directors of the Company (the “ Board ”) to serve as the Interim Chief Financial Officer of the Company, effective as of the Effective Date.
Departed
Giacomo Dall'Aglio
Chief Financial Officer
Kaleyra, Inc.
Giacomo Dall'Aglio was removed as the Company's Chief Financial Officer
Appointed
Danilo Roncasaglia
Chief Financial Officer
Kaleyra, Inc.
Danilo Roncasaglia was appointed as Chief Financial Officer of the Company
Appointed
Mauro Carobene
Chief Executive Officer
Kaleyra, Inc.
Mauro Carobene was appointed as Chief Executive Officer of the Company
Departed
Jon Garfield
Chief Financial Officer
ONCO ·
Onconetix, Inc.
Effective as of October 4, 2023, Jon Garfield resigned as Chief Financial Officer of the Company.
Appointed
Neil Campbell
President and Chief Executive Officer
ONCO ·
Onconetix, Inc.
appointed Dr. Neil Campbell, 63, as President and Chief Executive Officer of the Company and as a member of the Board of Directors
Departed
Dennis Bertolotti
President and Chief Executive Officer
MG ·
Mistras Group, Inc.
On October 9, 2023, the Board also approved the termination without cause of Dennis Bertolotti as the Company’s President and Chief Executive Officer, effective immediately.
Role change
(interim)
Manuel N. Stamatakis
Interim President and Chief Executive Officer
MG ·
Mistras Group, Inc.
the Board appointed Mr. Stamatakis to serve as interim President and Chief Executive Officer until a permanent President and Chief Executive Officer has been appointed.
Appointed
Neil F. McFarlane
President and Chief Executive Officer
ZVRA ·
ZEVRA THERAPEUTICS, INC.
appointed Neil F. McFarlane to serve as the Company’s President and Chief Executive Officer, effective October 10, 2023
Appointed
Andrew Trumbach
Chief Financial Officer
AWCA ·
Awaysis Capital, Inc.
Andrew Trumbach, the Company’s current President and a director, was reappointed as Chief Financial Officer of the Company to replace Mr. Vasquez.
Departed
Amir Vasquez
Chief Financial Officer
AWCA ·
Awaysis Capital, Inc.
accepted the resignation of Amir Vasquez, the Company’s then-Chief Financial Officer.
Departed
Andrew D. Sklawer
President and Chief Executive Officer
Fresh Tracks Therapeutics, Inc.
the Company terminated Andrew D. Sklawer, the Company’s President and Chief Executive Officer, without cause, effective October 2, 2023
Role change
Thane Wettig
Chief Executive Officer
KYNB ·
KYNTRA BIO, INC.
On October 2, 2023, the Board of Directors (the “Board”) of FibroGen, Inc. (the “Company”) appointed Interim Chief Executive Officer Thane Wettig as (i) Chief Executive Officer and (ii) a member of the Board.
Role change
James G. Petcoff
Executive Chairman and Co-Chief Executive Officer
PRHI ·
Presurance Holdings, Inc.
Consequently, James G. Petcoff will be stepping down as Executive Chairman and Co-Chief Executive Officer, effective December 31, 2023.
Role change
Nicholas J. Petcoff
Chief Executive Officer
PRHI ·
Presurance Holdings, Inc.
Effective December 31, 2023, Nicholas J. Petcoff will become sole Chief Executive Officer of Conifer Holdings, Inc.
Appointed
(interim)
Craig K. Clement
interim Chief Executive Officer
DTGI ·
Digerati Technologies, Inc.
On October 6, 2023, the Board of Directors of the Company (the “Board”) appointed Craig K. Clement, the current Executive Chairman of the Company, as interim CEO during Mr. Smith’s temporary medical leave of absence.
Departed
Arthur L. Smith
Chief Executive Officer
DTGI ·
Digerati Technologies, Inc.
On October 6, 2023, Arthur L. Smith, the Chief Executive Officer (“CEO”) of Digerati Technologies, Inc. (the “Company”), notified the Company that he will take a temporary medical leave of absence from his role as CEO, effective immediately, in connection with his recent surgery.
Role change
Raynauld Liang
Chief Executive Officer
SOPA ·
SOCIETY PASS INCORPORATED.
On October 5, 2023, Raynauld Liang was appointed as the new Chief Executive Officer of the Company.
Departed
Dennis Nguyen
Director, Chairman and Chief Executive Officer
SOPA ·
SOCIETY PASS INCORPORATED.
Mr. Liang’s appointment was concurrent with the resignation of Dennis Nguyen, on October 5, 2023, as a director of the Company, and as the Chairman and the Chief Executive Officer of the Company
Appointed
Yee Siong Tan
Chief Financial Officer
SOPA ·
SOCIETY PASS INCORPORATED.
In conjunction with Mr. Liang’s resignation, Yee Siong Tan was appointed as the Chief Financial Officer of the Company.
Appointed
Joseph Mullin
Chief Executive Officer and President
RYES ·
Rise Gold Corp.
pursuant to which the Company has engaged the Consultant to provide consulting services to the Company, including providing the services of Mr. Mullin on a 50% time commitment basis as the Company's Chief Executive Officer and President
Role change
Matthew Franklin
President and Chief Executive Officer
Akili, Inc.
the appointment of Matthew Franklin, the Company’s President and Chief Operating Officer, to President and Chief Executive Officer and principal executive officer of the Company, effective as of the Transition Date.
Appointed
(interim)
Natalie McAndrew
Interim Chief Financial Officer
Baudax Bio, Inc.
On October 5, 2023, the board of directors of the Company appointed Natalie McAndrew as Interim Chief Financial Officer, effective as of the Effective Date.
Departed
Teresa Luong
Chief Financial Officer
TrueCar, Inc.
the Company had terminated the employment of Teresa Luong as Chief Financial Officer of the Company effective October 2, 2023.
Departed
Greg Weaver
Executive Vice President and Chief Financial Officer
ATOS ·
ATOSSA THERAPEUTICS, INC.
Mr. Weaver tendered his resignation to pursue other opportunities and not due to any disagreement with the Company.
Appointed
Heather Rees
principal financial and accounting officer
ATOS ·
ATOSSA THERAPEUTICS, INC.
In connection with Mr. Weaver’s resignation, the Company has appointed Heather Rees, age 51, as the Company’s principal financial and accounting officer.
Appointed
(interim)
Scott Cox
Interim Chief Executive Officer
THC Therapeutics, Inc.
Scott Cox was appointed as Interim CEO of the Company
Departed
Brandon Romanek
Chief Executive Officer
THC Therapeutics, Inc.
On September 29, 2023, Brandon Romanek resigned as CEO of THC Therapeutics, Inc.
Departed
Simon Allen
Chief Executive Officer
ANEB ·
Anebulo Pharmaceuticals, Inc.
On October 6, 2023, Anebulo Pharmaceuticals, Inc., a Delaware corporation (the “Company”), terminated without cause the employment of Simon Allen, the Company’s Chief Executive Officer.
Appointed
Richard (Richie) Anthony Cunningham
Chief Executive Officer
ANEB ·
Anebulo Pharmaceuticals, Inc.
the Board appointed Richard (Richie) Anthony Cunningham as the Company’s Chief Executive Officer and as a member of the Board.
Appointed
Craig Shore
Chief Financial Officer, Secretary and Treasurer
NSPR ·
InspireMD, Inc.
On October 5, 2023, Mr. Shore was reappointed as the Chief Financial Officer, Secretary and Treasurer of the Company.
Appointed
Gurvinder Singh
Chief Executive Officer
Bright Green Corp
Gurvinder Singh was appointed Chief Executive Officer of the Company, effective as of October 2, 2023.
Departed
Seamus McAuley
Chief Executive Officer
Bright Green Corp
Effective as of October 2, 2023, Seamus McAuley, the Chief Executive Officer of Bright Green Corporation, a Delaware corporation (the “Company”), resigned from his position as Chief Executive Officer of the Company in connection with the appointment of Gurvinder Singh as Chief Executive Officer, as described below.
Departed
Michael C. Pearl
Vice President, Chief Financial Officer and Treasurer
USAC ·
USA Compression Partners, LP
On October 5, 2023, Michael C. Pearl, Vice President, Chief Financial Officer and Treasurer of USA Compression GP, LLC (the “ Company ”), the general partner of USA Compression Partners, LP (the “ Partnership ”), submitted his resignation to pursue other opportunities.
Appointed
G. Tracy Owens
principal financial officer
USAC ·
USA Compression Partners, LP
On October 5, 2023, the board of directors of the Company designated G. Tracy Owens to serve as the principal financial officer of the Company, to be effective October 6, 2023.
Appointed
George N. Mattson
Chief Executive Officer
UP ·
Wheels Up Experience Inc.
on October 2, 2023, Mr. Mattson joined the Company as Chief Executive Officer
Appointed
Sandra L. Rivera
Chief Executive Officer of Programmable Solutions Group
INTC ·
INTEL CORP
On October 3, 2023, Intel Corporation (“Intel”) announced that Sandra L. Rivera will assume the role of Chief Executive Officer of Programmable Solutions Group (“PSG”), an Intel standalone business, and the effective date of this transition (“Effective Date”) is anticipated to occur on January 1, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.